HEMATOL ONCOL 润色咨询

HEMATOLOGICAL ONCOLOGY

出版年份：1983 年文章数：702 投稿命中率： 开通期刊会员，数据随心看

出版周期：Quarterly 自引率：6.0% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2106038, encodeId=4414210603849, content=审稿费需要70欧元，交了一下午都交不了，见鬼了这杂志，只能换别家啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKbuMTogxT82iaafNzKneXa0pOJ6F14K57vK0W8Loxkibl2ZfjgtmlJbEFbpIv4qpjuqhhoK05tzibWw/132, createdBy=89622105481, createdName=一梦十寒, createdTime=Wed Dec 14 17:34:03 CST 2022, time=2022-12-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2101385, encodeId=06aa21013854d, content=有没有遇到过找回密码的时候，明明输入的邮箱里的验证码是正确的，但每次都提示验证码错误, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9cf88119039, createdName=ms4000000003692748, createdTime=Fri Nov 18 20:48:56 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207026, encodeId=dd6f120e02658, content=这个不是英国出版的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=004a6458515, createdName=ms1000000636745971, createdTime=Tue Mar 29 21:35:36 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200689, encodeId=5d6f12006896a, content=请问这个只收血液方面的肿瘤文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57ac6408873, createdName=ms1000001634469271, createdTime=Tue Mar 08 21:45:20 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=476900, encodeId=7da14e69000b, content=偏重的研究方向：肿瘤;癌症;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=351b28084, createdName=hitzhxb, createdTime=Tue Jun 28 15:57:00 CST 2011, time=2011-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906851, encodeId=e7359068513b, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：2020-9-1投稿 ，2020-10-6大修 2020-12-1修回 2020-12-6 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=339947499, createdName=kdsheng190, createdTime=Thu Dec 10 21:39:03 CST 2020, time=2020-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091068, encodeId=acb5109106860, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091067, encodeId=640c109106e8a, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083693, encodeId=6cb5108369395, content=虽然难受，还是分享一下经验: 12－15投稿，12－23被拒了 没有理由，就说投稿太多了 可以试一下，毕竟拒稿速度还是可以的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df3a5075432, createdName=145a077bm97暂无昵称, createdTime=Thu Dec 23 22:23:14 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080206, encodeId=2d9e1080206e5, content=受益匪浅 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=LFRRP6YqrAia0BryFmv6ibnA&s=100&t=1555426989, createdBy=79c45230339, createdName=刘晓捷, createdTime=Wed Dec 15 08:50:55 CST 2021, time=2021-12-15, status=1, ipAttribution=)]
    2022-12-14 一梦十寒 来自湖北省

    审稿费需要70欧元，交了一下午都交不了，见鬼了这杂志，只能换别家啦

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2106038, encodeId=4414210603849, content=审稿费需要70欧元，交了一下午都交不了，见鬼了这杂志，只能换别家啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKbuMTogxT82iaafNzKneXa0pOJ6F14K57vK0W8Loxkibl2ZfjgtmlJbEFbpIv4qpjuqhhoK05tzibWw/132, createdBy=89622105481, createdName=一梦十寒, createdTime=Wed Dec 14 17:34:03 CST 2022, time=2022-12-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2101385, encodeId=06aa21013854d, content=有没有遇到过找回密码的时候，明明输入的邮箱里的验证码是正确的，但每次都提示验证码错误, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9cf88119039, createdName=ms4000000003692748, createdTime=Fri Nov 18 20:48:56 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207026, encodeId=dd6f120e02658, content=这个不是英国出版的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=004a6458515, createdName=ms1000000636745971, createdTime=Tue Mar 29 21:35:36 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200689, encodeId=5d6f12006896a, content=请问这个只收血液方面的肿瘤文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57ac6408873, createdName=ms1000001634469271, createdTime=Tue Mar 08 21:45:20 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=476900, encodeId=7da14e69000b, content=偏重的研究方向：肿瘤;癌症;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=351b28084, createdName=hitzhxb, createdTime=Tue Jun 28 15:57:00 CST 2011, time=2011-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906851, encodeId=e7359068513b, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：2020-9-1投稿 ，2020-10-6大修 2020-12-1修回 2020-12-6 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=339947499, createdName=kdsheng190, createdTime=Thu Dec 10 21:39:03 CST 2020, time=2020-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091068, encodeId=acb5109106860, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091067, encodeId=640c109106e8a, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083693, encodeId=6cb5108369395, content=虽然难受，还是分享一下经验: 12－15投稿，12－23被拒了 没有理由，就说投稿太多了 可以试一下，毕竟拒稿速度还是可以的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df3a5075432, createdName=145a077bm97暂无昵称, createdTime=Thu Dec 23 22:23:14 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080206, encodeId=2d9e1080206e5, content=受益匪浅 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=LFRRP6YqrAia0BryFmv6ibnA&s=100&t=1555426989, createdBy=79c45230339, createdName=刘晓捷, createdTime=Wed Dec 15 08:50:55 CST 2021, time=2021-12-15, status=1, ipAttribution=)]
    2022-11-18 ms4000000003692748

    有没有遇到过找回密码的时候，明明输入的邮箱里的验证码是正确的，但每次都提示验证码错误

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2106038, encodeId=4414210603849, content=审稿费需要70欧元，交了一下午都交不了，见鬼了这杂志，只能换别家啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKbuMTogxT82iaafNzKneXa0pOJ6F14K57vK0W8Loxkibl2ZfjgtmlJbEFbpIv4qpjuqhhoK05tzibWw/132, createdBy=89622105481, createdName=一梦十寒, createdTime=Wed Dec 14 17:34:03 CST 2022, time=2022-12-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2101385, encodeId=06aa21013854d, content=有没有遇到过找回密码的时候，明明输入的邮箱里的验证码是正确的，但每次都提示验证码错误, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9cf88119039, createdName=ms4000000003692748, createdTime=Fri Nov 18 20:48:56 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207026, encodeId=dd6f120e02658, content=这个不是英国出版的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=004a6458515, createdName=ms1000000636745971, createdTime=Tue Mar 29 21:35:36 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200689, encodeId=5d6f12006896a, content=请问这个只收血液方面的肿瘤文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57ac6408873, createdName=ms1000001634469271, createdTime=Tue Mar 08 21:45:20 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=476900, encodeId=7da14e69000b, content=偏重的研究方向：肿瘤;癌症;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=351b28084, createdName=hitzhxb, createdTime=Tue Jun 28 15:57:00 CST 2011, time=2011-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906851, encodeId=e7359068513b, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：2020-9-1投稿 ，2020-10-6大修 2020-12-1修回 2020-12-6 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=339947499, createdName=kdsheng190, createdTime=Thu Dec 10 21:39:03 CST 2020, time=2020-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091068, encodeId=acb5109106860, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091067, encodeId=640c109106e8a, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083693, encodeId=6cb5108369395, content=虽然难受，还是分享一下经验: 12－15投稿，12－23被拒了 没有理由，就说投稿太多了 可以试一下，毕竟拒稿速度还是可以的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df3a5075432, createdName=145a077bm97暂无昵称, createdTime=Thu Dec 23 22:23:14 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080206, encodeId=2d9e1080206e5, content=受益匪浅 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=LFRRP6YqrAia0BryFmv6ibnA&s=100&t=1555426989, createdBy=79c45230339, createdName=刘晓捷, createdTime=Wed Dec 15 08:50:55 CST 2021, time=2021-12-15, status=1, ipAttribution=)]
    2022-03-29 ms1000000636745971

    这个不是英国出版的吗？

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2106038, encodeId=4414210603849, content=审稿费需要70欧元，交了一下午都交不了，见鬼了这杂志，只能换别家啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKbuMTogxT82iaafNzKneXa0pOJ6F14K57vK0W8Loxkibl2ZfjgtmlJbEFbpIv4qpjuqhhoK05tzibWw/132, createdBy=89622105481, createdName=一梦十寒, createdTime=Wed Dec 14 17:34:03 CST 2022, time=2022-12-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2101385, encodeId=06aa21013854d, content=有没有遇到过找回密码的时候，明明输入的邮箱里的验证码是正确的，但每次都提示验证码错误, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9cf88119039, createdName=ms4000000003692748, createdTime=Fri Nov 18 20:48:56 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207026, encodeId=dd6f120e02658, content=这个不是英国出版的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=004a6458515, createdName=ms1000000636745971, createdTime=Tue Mar 29 21:35:36 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200689, encodeId=5d6f12006896a, content=请问这个只收血液方面的肿瘤文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57ac6408873, createdName=ms1000001634469271, createdTime=Tue Mar 08 21:45:20 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=476900, encodeId=7da14e69000b, content=偏重的研究方向：肿瘤;癌症;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=351b28084, createdName=hitzhxb, createdTime=Tue Jun 28 15:57:00 CST 2011, time=2011-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906851, encodeId=e7359068513b, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：2020-9-1投稿 ，2020-10-6大修 2020-12-1修回 2020-12-6 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=339947499, createdName=kdsheng190, createdTime=Thu Dec 10 21:39:03 CST 2020, time=2020-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091068, encodeId=acb5109106860, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091067, encodeId=640c109106e8a, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083693, encodeId=6cb5108369395, content=虽然难受，还是分享一下经验: 12－15投稿，12－23被拒了 没有理由，就说投稿太多了 可以试一下，毕竟拒稿速度还是可以的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df3a5075432, createdName=145a077bm97暂无昵称, createdTime=Thu Dec 23 22:23:14 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080206, encodeId=2d9e1080206e5, content=受益匪浅 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=LFRRP6YqrAia0BryFmv6ibnA&s=100&t=1555426989, createdBy=79c45230339, createdName=刘晓捷, createdTime=Wed Dec 15 08:50:55 CST 2021, time=2021-12-15, status=1, ipAttribution=)]
    2022-03-08 ms1000001634469271

    请问这个只收血液方面的肿瘤文章吗？

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2106038, encodeId=4414210603849, content=审稿费需要70欧元，交了一下午都交不了，见鬼了这杂志，只能换别家啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKbuMTogxT82iaafNzKneXa0pOJ6F14K57vK0W8Loxkibl2ZfjgtmlJbEFbpIv4qpjuqhhoK05tzibWw/132, createdBy=89622105481, createdName=一梦十寒, createdTime=Wed Dec 14 17:34:03 CST 2022, time=2022-12-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2101385, encodeId=06aa21013854d, content=有没有遇到过找回密码的时候，明明输入的邮箱里的验证码是正确的，但每次都提示验证码错误, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9cf88119039, createdName=ms4000000003692748, createdTime=Fri Nov 18 20:48:56 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207026, encodeId=dd6f120e02658, content=这个不是英国出版的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=004a6458515, createdName=ms1000000636745971, createdTime=Tue Mar 29 21:35:36 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200689, encodeId=5d6f12006896a, content=请问这个只收血液方面的肿瘤文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57ac6408873, createdName=ms1000001634469271, createdTime=Tue Mar 08 21:45:20 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=476900, encodeId=7da14e69000b, content=偏重的研究方向：肿瘤;癌症;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=351b28084, createdName=hitzhxb, createdTime=Tue Jun 28 15:57:00 CST 2011, time=2011-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906851, encodeId=e7359068513b, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：2020-9-1投稿 ，2020-10-6大修 2020-12-1修回 2020-12-6 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=339947499, createdName=kdsheng190, createdTime=Thu Dec 10 21:39:03 CST 2020, time=2020-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091068, encodeId=acb5109106860, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091067, encodeId=640c109106e8a, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083693, encodeId=6cb5108369395, content=虽然难受，还是分享一下经验: 12－15投稿，12－23被拒了 没有理由，就说投稿太多了 可以试一下，毕竟拒稿速度还是可以的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df3a5075432, createdName=145a077bm97暂无昵称, createdTime=Thu Dec 23 22:23:14 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080206, encodeId=2d9e1080206e5, content=受益匪浅 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=LFRRP6YqrAia0BryFmv6ibnA&s=100&t=1555426989, createdBy=79c45230339, createdName=刘晓捷, createdTime=Wed Dec 15 08:50:55 CST 2021, time=2021-12-15, status=1, ipAttribution=)]
    2011-06-28 hitzhxb

    偏重的研究方向：肿瘤;癌症;

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2106038, encodeId=4414210603849, content=审稿费需要70欧元，交了一下午都交不了，见鬼了这杂志，只能换别家啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKbuMTogxT82iaafNzKneXa0pOJ6F14K57vK0W8Loxkibl2ZfjgtmlJbEFbpIv4qpjuqhhoK05tzibWw/132, createdBy=89622105481, createdName=一梦十寒, createdTime=Wed Dec 14 17:34:03 CST 2022, time=2022-12-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2101385, encodeId=06aa21013854d, content=有没有遇到过找回密码的时候，明明输入的邮箱里的验证码是正确的，但每次都提示验证码错误, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9cf88119039, createdName=ms4000000003692748, createdTime=Fri Nov 18 20:48:56 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207026, encodeId=dd6f120e02658, content=这个不是英国出版的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=004a6458515, createdName=ms1000000636745971, createdTime=Tue Mar 29 21:35:36 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200689, encodeId=5d6f12006896a, content=请问这个只收血液方面的肿瘤文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57ac6408873, createdName=ms1000001634469271, createdTime=Tue Mar 08 21:45:20 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=476900, encodeId=7da14e69000b, content=偏重的研究方向：肿瘤;癌症;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=351b28084, createdName=hitzhxb, createdTime=Tue Jun 28 15:57:00 CST 2011, time=2011-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906851, encodeId=e7359068513b, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：2020-9-1投稿 ，2020-10-6大修 2020-12-1修回 2020-12-6 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=339947499, createdName=kdsheng190, createdTime=Thu Dec 10 21:39:03 CST 2020, time=2020-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091068, encodeId=acb5109106860, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091067, encodeId=640c109106e8a, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083693, encodeId=6cb5108369395, content=虽然难受，还是分享一下经验: 12－15投稿，12－23被拒了 没有理由，就说投稿太多了 可以试一下，毕竟拒稿速度还是可以的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df3a5075432, createdName=145a077bm97暂无昵称, createdTime=Thu Dec 23 22:23:14 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080206, encodeId=2d9e1080206e5, content=受益匪浅 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=LFRRP6YqrAia0BryFmv6ibnA&s=100&t=1555426989, createdBy=79c45230339, createdName=刘晓捷, createdTime=Wed Dec 15 08:50:55 CST 2021, time=2021-12-15, status=1, ipAttribution=)]
    2020-12-10 kdsheng190

    审稿速度:1.0 | 投稿命中率:50.0
    经验分享：2020-9-1投稿 ，2020-10-6大修 2020-12-1修回 2020-12-6 接收

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2106038, encodeId=4414210603849, content=审稿费需要70欧元，交了一下午都交不了，见鬼了这杂志，只能换别家啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKbuMTogxT82iaafNzKneXa0pOJ6F14K57vK0W8Loxkibl2ZfjgtmlJbEFbpIv4qpjuqhhoK05tzibWw/132, createdBy=89622105481, createdName=一梦十寒, createdTime=Wed Dec 14 17:34:03 CST 2022, time=2022-12-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2101385, encodeId=06aa21013854d, content=有没有遇到过找回密码的时候，明明输入的邮箱里的验证码是正确的，但每次都提示验证码错误, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9cf88119039, createdName=ms4000000003692748, createdTime=Fri Nov 18 20:48:56 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207026, encodeId=dd6f120e02658, content=这个不是英国出版的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=004a6458515, createdName=ms1000000636745971, createdTime=Tue Mar 29 21:35:36 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200689, encodeId=5d6f12006896a, content=请问这个只收血液方面的肿瘤文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57ac6408873, createdName=ms1000001634469271, createdTime=Tue Mar 08 21:45:20 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=476900, encodeId=7da14e69000b, content=偏重的研究方向：肿瘤;癌症;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=351b28084, createdName=hitzhxb, createdTime=Tue Jun 28 15:57:00 CST 2011, time=2011-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906851, encodeId=e7359068513b, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：2020-9-1投稿 ，2020-10-6大修 2020-12-1修回 2020-12-6 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=339947499, createdName=kdsheng190, createdTime=Thu Dec 10 21:39:03 CST 2020, time=2020-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091068, encodeId=acb5109106860, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091067, encodeId=640c109106e8a, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083693, encodeId=6cb5108369395, content=虽然难受，还是分享一下经验: 12－15投稿，12－23被拒了 没有理由，就说投稿太多了 可以试一下，毕竟拒稿速度还是可以的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df3a5075432, createdName=145a077bm97暂无昵称, createdTime=Thu Dec 23 22:23:14 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080206, encodeId=2d9e1080206e5, content=受益匪浅 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=LFRRP6YqrAia0BryFmv6ibnA&s=100&t=1555426989, createdBy=79c45230339, createdName=刘晓捷, createdTime=Wed Dec 15 08:50:55 CST 2021, time=2021-12-15, status=1, ipAttribution=)]
    2021-12-29 msSSSSSD

    引言中文章的创新性如何体现？

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2106038, encodeId=4414210603849, content=审稿费需要70欧元，交了一下午都交不了，见鬼了这杂志，只能换别家啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKbuMTogxT82iaafNzKneXa0pOJ6F14K57vK0W8Loxkibl2ZfjgtmlJbEFbpIv4qpjuqhhoK05tzibWw/132, createdBy=89622105481, createdName=一梦十寒, createdTime=Wed Dec 14 17:34:03 CST 2022, time=2022-12-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2101385, encodeId=06aa21013854d, content=有没有遇到过找回密码的时候，明明输入的邮箱里的验证码是正确的，但每次都提示验证码错误, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9cf88119039, createdName=ms4000000003692748, createdTime=Fri Nov 18 20:48:56 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207026, encodeId=dd6f120e02658, content=这个不是英国出版的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=004a6458515, createdName=ms1000000636745971, createdTime=Tue Mar 29 21:35:36 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200689, encodeId=5d6f12006896a, content=请问这个只收血液方面的肿瘤文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57ac6408873, createdName=ms1000001634469271, createdTime=Tue Mar 08 21:45:20 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=476900, encodeId=7da14e69000b, content=偏重的研究方向：肿瘤;癌症;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=351b28084, createdName=hitzhxb, createdTime=Tue Jun 28 15:57:00 CST 2011, time=2011-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906851, encodeId=e7359068513b, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：2020-9-1投稿 ，2020-10-6大修 2020-12-1修回 2020-12-6 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=339947499, createdName=kdsheng190, createdTime=Thu Dec 10 21:39:03 CST 2020, time=2020-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091068, encodeId=acb5109106860, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091067, encodeId=640c109106e8a, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083693, encodeId=6cb5108369395, content=虽然难受，还是分享一下经验: 12－15投稿，12－23被拒了 没有理由，就说投稿太多了 可以试一下，毕竟拒稿速度还是可以的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df3a5075432, createdName=145a077bm97暂无昵称, createdTime=Thu Dec 23 22:23:14 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080206, encodeId=2d9e1080206e5, content=受益匪浅 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=LFRRP6YqrAia0BryFmv6ibnA&s=100&t=1555426989, createdBy=79c45230339, createdName=刘晓捷, createdTime=Wed Dec 15 08:50:55 CST 2021, time=2021-12-15, status=1, ipAttribution=)]
    2021-12-28 小动量

    引言需要写什么内容？

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2106038, encodeId=4414210603849, content=审稿费需要70欧元，交了一下午都交不了，见鬼了这杂志，只能换别家啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKbuMTogxT82iaafNzKneXa0pOJ6F14K57vK0W8Loxkibl2ZfjgtmlJbEFbpIv4qpjuqhhoK05tzibWw/132, createdBy=89622105481, createdName=一梦十寒, createdTime=Wed Dec 14 17:34:03 CST 2022, time=2022-12-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2101385, encodeId=06aa21013854d, content=有没有遇到过找回密码的时候，明明输入的邮箱里的验证码是正确的，但每次都提示验证码错误, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9cf88119039, createdName=ms4000000003692748, createdTime=Fri Nov 18 20:48:56 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207026, encodeId=dd6f120e02658, content=这个不是英国出版的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=004a6458515, createdName=ms1000000636745971, createdTime=Tue Mar 29 21:35:36 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200689, encodeId=5d6f12006896a, content=请问这个只收血液方面的肿瘤文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57ac6408873, createdName=ms1000001634469271, createdTime=Tue Mar 08 21:45:20 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=476900, encodeId=7da14e69000b, content=偏重的研究方向：肿瘤;癌症;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=351b28084, createdName=hitzhxb, createdTime=Tue Jun 28 15:57:00 CST 2011, time=2011-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906851, encodeId=e7359068513b, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：2020-9-1投稿 ，2020-10-6大修 2020-12-1修回 2020-12-6 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=339947499, createdName=kdsheng190, createdTime=Thu Dec 10 21:39:03 CST 2020, time=2020-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091068, encodeId=acb5109106860, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091067, encodeId=640c109106e8a, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083693, encodeId=6cb5108369395, content=虽然难受，还是分享一下经验: 12－15投稿，12－23被拒了 没有理由，就说投稿太多了 可以试一下，毕竟拒稿速度还是可以的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df3a5075432, createdName=145a077bm97暂无昵称, createdTime=Thu Dec 23 22:23:14 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080206, encodeId=2d9e1080206e5, content=受益匪浅 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=LFRRP6YqrAia0BryFmv6ibnA&s=100&t=1555426989, createdBy=79c45230339, createdName=刘晓捷, createdTime=Wed Dec 15 08:50:55 CST 2021, time=2021-12-15, status=1, ipAttribution=)]
    2021-12-23 145a077bm97暂无昵称

    虽然难受，还是分享一下经验: 12－15投稿，12－23被拒了 没有理由，就说投稿太多了 可以试一下，毕竟拒稿速度还是可以的

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2106038, encodeId=4414210603849, content=审稿费需要70欧元，交了一下午都交不了，见鬼了这杂志，只能换别家啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKbuMTogxT82iaafNzKneXa0pOJ6F14K57vK0W8Loxkibl2ZfjgtmlJbEFbpIv4qpjuqhhoK05tzibWw/132, createdBy=89622105481, createdName=一梦十寒, createdTime=Wed Dec 14 17:34:03 CST 2022, time=2022-12-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2101385, encodeId=06aa21013854d, content=有没有遇到过找回密码的时候，明明输入的邮箱里的验证码是正确的，但每次都提示验证码错误, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9cf88119039, createdName=ms4000000003692748, createdTime=Fri Nov 18 20:48:56 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207026, encodeId=dd6f120e02658, content=这个不是英国出版的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=004a6458515, createdName=ms1000000636745971, createdTime=Tue Mar 29 21:35:36 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200689, encodeId=5d6f12006896a, content=请问这个只收血液方面的肿瘤文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57ac6408873, createdName=ms1000001634469271, createdTime=Tue Mar 08 21:45:20 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=476900, encodeId=7da14e69000b, content=偏重的研究方向：肿瘤;癌症;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=351b28084, createdName=hitzhxb, createdTime=Tue Jun 28 15:57:00 CST 2011, time=2011-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906851, encodeId=e7359068513b, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：2020-9-1投稿 ，2020-10-6大修 2020-12-1修回 2020-12-6 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=339947499, createdName=kdsheng190, createdTime=Thu Dec 10 21:39:03 CST 2020, time=2020-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091068, encodeId=acb5109106860, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091067, encodeId=640c109106e8a, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083693, encodeId=6cb5108369395, content=虽然难受，还是分享一下经验: 12－15投稿，12－23被拒了 没有理由，就说投稿太多了 可以试一下，毕竟拒稿速度还是可以的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df3a5075432, createdName=145a077bm97暂无昵称, createdTime=Thu Dec 23 22:23:14 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080206, encodeId=2d9e1080206e5, content=受益匪浅 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=LFRRP6YqrAia0BryFmv6ibnA&s=100&t=1555426989, createdBy=79c45230339, createdName=刘晓捷, createdTime=Wed Dec 15 08:50:55 CST 2021, time=2021-12-15, status=1, ipAttribution=)]
    2021-12-15 刘晓捷

    受益匪浅

    0

共29条页码: 1/3页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分